Since at least half of TAL‐deficient patients will have severe liver disease (cirrhosis or HCC), conservatively, TAL deficiency may account for liver disease in less than one of 30 (3.3%) patients. The gene discussed is TALDO1; the disease is hepatocellular carcinoma.